fluorodeoxyglucose f18 has been researched along with Experimental Mammary Neoplasms in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (10.71) | 18.7374 |
1990's | 15 (26.79) | 18.2507 |
2000's | 15 (26.79) | 29.6817 |
2010's | 19 (33.93) | 24.3611 |
2020's | 1 (1.79) | 2.80 |
Authors | Studies |
---|---|
Dufour, J; Richter, S; Wagner, M; West, FG; Wuest, F; Wuest, M; Yuen, R | 1 |
Chen, Q; Chen, Y; Dong, Y; Liu, H; Song, F; Tian, M; Wang, L; Wu, S; Xu, C; Zhang, H; Zhang, K; Zhou, M; Zhu, Y | 1 |
Kang, SH; Kim, D; Kim, M; Kim, SW; Park, SH; Shin, SH | 1 |
Kiru, L; Naczynski, DJ; Pratx, G; Sasportas, LS; Türkcan, S | 1 |
Aarnes, EK; Alluri, SR; Kristian, A; Lyng, H; Malinen, E; Pitman, KE; Riss, PJ | 1 |
Cauchon, N; Hasséssian, HM; Lecomte, R; Turcotte, E; van Lier, JE | 1 |
Allen, JA; Chan, SR; Dehdashti, F; Dence, CS; Fettig, NM; Fowler, AM; Katzenellenbogen, JA; Sharp, TL; Zhou, D | 1 |
Kristian, A; Malinen, E; Pitman, KE; Rusten, E | 1 |
Acha-Ngwodo, O; Buijs, M; Engles, JM; Geschwind, JF; Ishimori, T; Vali, M; Vossen, JA; Wahl, RL | 1 |
Ansari, MS; Arteaga, CL; Baldwin, RM; Buck, JR; Gore, JC; Manning, HC; McKinley, ET; Miller, TW; Nolting, DD; Olivares, MG; Sanchez, V; Schiff, R; Shah, C; Wyatt, SK; Zhao, P | 1 |
Devadhas, D; McCue, P; Pestell, RG; Thakur, ML; Wang, C; Wickstrom, E; Zhang, K | 1 |
Buser, C; Clark, EA; Coppola, D; Draetta, GF; Efferson, CL; Giampaoli, S; Gibson, RE; Majumder, PK; Mesiti, G; Patel, S; Reilly, JF; Strack, PR; Sullivan, T; Tammam, J; Ware, C; Winkelmann, CT; Winter, C; Yeatman, T | 1 |
Boschi, F; Calandrino, R; Calderan, L; D'Ambrosio, D; Fenzi, A; Marengo, M; Sbarbati, A; Spinelli, AE | 1 |
Cao, Q; Chen, X; Liu, S; Neamati, N; Niu, G; Shen, B; Sun, X; Yan, Y; Yang, M | 1 |
Archambault, M; Bénard, F; Croteau, É; Lecomte, R; Ouellet, R; Paquette, M | 1 |
Bai, J; Liu, F; Liu, S; Luo, J; Shan, B; Xu, Y; Zhang, B; Zhang, X | 1 |
Cauchon, N; Hasséssian, HM; Lecomte, R; Lier, JE; Turcotte, E | 1 |
Ali, MS; Kong, FL; Rollo, A; Smith, DL; Yang, DJ; Yu, DF; Zhang, Y | 1 |
Aras, O; Bagci, U; Bernardo, M; Capala, J; Choyke, P; Kiesewetter, DO; Kramer-Marek, G; Kuban, M; Omer, A; Seidel, J; Zielinski, R | 1 |
Ayers, GD; Fluckiger, JU; Peterson, TE; Tantawy, MN; Whisenant, JG; Yankeelov, TE | 1 |
Carlson, KE; Chan, SR; Dence, CS; Fettig, NM; Fowler, AM; Jeyakumar, M; Katzenellenbogen, JA; Schreiber, RD; Sharp, TL; Welch, MJ; Zhou, D | 1 |
Appleyard, MV; Fleming, IN; Murray, K; Sharp, S; Smith, TA; Thompson, AM | 1 |
Patt, M; Scheunemann, M; Sorger, D; Stöcklin, G | 1 |
Aft, RL; Kim, J; Lewis, JS; Welch, MJ; Zhang, F | 1 |
Geschwind, JF; Marshall, LT; Nakamoto, Y; Tatsumi, M; Traughber, B; Wahl, RL | 1 |
Mortimer, JE; Taylor, ME | 1 |
Blaufox, MD; Dadachova, E; Lin, EY; Lu, P; Mani, J; Moadel, RM; Nguyen, AV; Pollard, JW | 1 |
Meyer, MA | 1 |
Blaufox, MD; Charron, MJ; Dadachova, E; Katz, EB; Lu, P; Mani, J; Moadel, RM; Pestell, RG; Stahl, M; Weldon, RH | 1 |
Cumming, P; Horsman, MR; Keiding, S; Munk, OL; Sørensen, M | 1 |
Garbow, JR; Laforest, R; Rowland, DJ; Snyder, AZ | 1 |
Abbey, CK; Borowsky, AD; Cardiff, RD; Cherry, SR; Gregg, JP | 1 |
Henninger, H; Holstege, A; Keppler, DO; Reiffen, KA; Schneider, F; Schulz-Holstege, C | 1 |
Bergman, J; Haaparanta, M; Huovinen, R; Kangas, L; Kujari, H; Paul, R; Solin, O | 1 |
Brown, RS; Ethier, SP; Fisher, SJ; Frey, KA; Leung, JY; Wahl, RL | 2 |
Brown, RS; Ethier, SP; Fisher, SJ; Raylman, RR; Wahl, RL | 1 |
Iwata, R; Kubota, K; Kubota, R; Tada, M; Takahashi, T; Tamahashi, N; Yamada, S | 1 |
Ido, T; Kubota, K; Kubota, R; Tada, M; Tamahashi, N; Yamada, S | 2 |
Fisher, SJ; Torizuka, T; Wahl, RL | 1 |
Altmann, A; Berger, MR; Haag, D; Haberkorn, U; Oberdorfer, F; Peschke, P; Trojan, H; van Kaick, G; Ziegler, SI | 1 |
Brown, RS; Fisher, SJ; Torizuka, T; Wahl, RL | 1 |
Acton, PD; Dodd, NJ; Hastings, DL; Jeavons, AP; Moore, JV; Waller, ML; Zhao, S | 1 |
Hadfield, JA; Hastings, DL; McGown, AT; Moore, JV; Pettit, GR; Waller, ML; Zhao, S | 1 |
Brasseur, N; Cadorette, J; La Madeleine, C; Lapointe, D; Lecomte, R; Rodrigue, S; van Lier, JE | 1 |
Brooks, R; Carnochan, P | 1 |
Bentzen, L; Falborg, L; Hansen, SB; Horsman, MR; Keiding, S; Overgaard, J | 1 |
Buchheimer, N; Ehrenkaufer, RL; Huang, Y; Kuhner, R; Mach, RH; Morton, TE; Wallen, CA; Wang, L; Wheeler, KT; Wu, L | 1 |
Bender, D; Bentzen, L; Kaarstad, K; Keiding, S; Munk, OL | 1 |
Ethier, SP; Henry, CA; Wahl, RL | 1 |
Aho, K; Bergman, J; Haaparanta, M; Kulmala, J; Paul, R; Reissell, A; Solin, O | 1 |
Harju-Jeanty, R; Kangas, L; Kellokumpu-Lehtinen, P; Paul, R; Tuominen, J | 1 |
d'Argy, R; Frankenberg, L; Haaparanta, M; Halldin, C; Kangas, L; Lundqvist, H; Någren, K; Paul, R; Roeda, D; Stålnacke, CG | 1 |
Parviainen, S; Paul, R | 1 |
Abe, Y; Fujiwara, T; Fukuda, H; Ido, T; Itoh, M; Matsuzawa, T; Sato, T; Yamada, K; Yamaguchi, K | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Experimental Mammary Neoplasms
Article | Year |
---|---|
Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography.
Topics: Animals; Carcinoma in Situ; Carcinoma, Ductal, Breast; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Longitudinal Studies; Lymphatic Metastasis; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Positron-Emission Tomography; Whole-Body Counting | 2006 |
55 other study(ies) available for fluorodeoxyglucose f18 and Experimental Mammary Neoplasms
Article | Year |
---|---|
Design, synthesis, and evaluation of positron emission tomography/fluorescence dual imaging probes for targeting facilitated glucose transporter 1 (GLUT1).
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Fluorescent Dyes; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Mammary Neoplasms, Experimental; Mice; Molecular Structure; Optical Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
PET Imaging on Dynamic Metabolic Changes after Combination Therapy of Paclitaxel and the Traditional Chinese Medicine in Breast Cancer-Bearing Mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Fluorodeoxyglucose F18; Humans; Mammary Neoplasms, Experimental; Medicine, Chinese Traditional; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Positron-Emission Tomography | 2018 |
Fluorine-19 Magnetic Resonance Imaging and Positron Emission Tomography of Tumor-Associated Macrophages and Tumor Metabolism.
Topics: Animals; Female; Fluorine; Fluorine-19 Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Macrophages; Mammary Neoplasms, Experimental; Mice; Positron-Emission Tomography; Tumor Microenvironment | 2017 |
Lactic Acid Accumulation in the Tumor Microenvironment Suppresses
Topics: Animals; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Heterografts; Humans; Lactic Acid; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Radiopharmaceuticals; Tumor Microenvironment | 2019 |
Influx rate of
Topics: A549 Cells; Amino Acid Transport System y+; Amino Acids, Dicarboxylic; Animals; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Platelet Endothelial Cell Adhesion Molecule-1; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals | 2019 |
Deciphering PDT-induced inflammatory responses using real-time FDG-PET in a mouse tumour model.
Topics: Animals; Biological Transport; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Indomethacin; Inflammation; Lipopolysaccharides; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Photochemotherapy; Positron-Emission Tomography; Time Factors | 2014 |
Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.
Topics: Animals; Antineoplastic Agents, Hormonal; Biomarkers; Breast Neoplasms; Cell Line, Tumor; Diagnostic Imaging; Disease Models, Animal; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Humans; Ligands; Mammary Neoplasms, Experimental; Mice; Positron-Emission Tomography; Promegestone; Receptors, Progesterone; Tomography, X-Ray Computed | 2015 |
Variability of dynamic 18F-FDG-PET data in breast cancer xenografts.
Topics: Animals; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Heterografts; Mammary Neoplasms, Experimental; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms | 2015 |
Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glycolysis; Mammary Neoplasms, Experimental; Pyruvates; Rats; Rats, Inbred Lew | 2009 |
Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diagnostic Imaging; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mice, Transgenic; Positron-Emission Tomography; Prognosis; Receptor, ErbB-2; Reproducibility of Results; Trastuzumab; Xenograft Model Antitumor Assays | 2009 |
Imaging spontaneous MMTVneu transgenic murine mammary tumors: targeting metabolic activity versus genetic products.
Topics: Animals; Chromatography, High Pressure Liquid; Female; Fluorodeoxyglucose F18; Half-Life; Humans; Image Processing, Computer-Assisted; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Organometallic Compounds; Pituitary Adenylate Cyclase-Activating Polypeptide; Positron-Emission Tomography; Quality Control; Radiopharmaceuticals; Receptors, Vasoactive Intestinal Polypeptide, Type I; Reverse Transcriptase Polymerase Chain Reaction; Tomography, X-Ray Computed | 2010 |
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
Topics: Amyloid Precursor Protein Secretases; Animals; Breast Neoplasms; Cyclic S-Oxides; Down-Regulation; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Intracellular Signaling Peptides and Proteins; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Transgenic; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Receptor, ErbB-2; Receptors, Notch; Signal Transduction; Thiadiazoles; TOR Serine-Threonine Kinases | 2010 |
In vivo ¹⁸F-FDG tumour uptake measurements in small animals using Cerenkov radiation.
Topics: Animals; Biological Transport; Female; Fluorodeoxyglucose F18; Mammary Neoplasms, Experimental; Mice; Positron-Emission Tomography; Time Factors | 2011 |
18F-FPPRGD2 and 18F-FDG PET of response to Abraxane therapy.
Topics: Albumin-Bound Paclitaxel; Albumins; Animals; Antineoplastic Agents; Cell Line, Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Mammary Neoplasms, Experimental; Mice; Oligopeptides; Paclitaxel; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals; Xenograft Model Antitumor Assays | 2011 |
[18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen | 2012 |
Simultaneous fluorescence and positron emission tomography for in vivo imaging of small animals.
Topics: Animals; Female; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Spectrometry, Fluorescence | 2011 |
Predicting efficacy of photodynamic therapy by real-time FDG-PET in a mouse tumour model.
Topics: Animals; Biological Transport; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Photochemotherapy; Positron-Emission Tomography; Time Factors; Treatment Outcome | 2012 |
Development of tyrosine-based radiotracer 99mTc-N4-Tyrosine for breast cancer imaging.
Topics: Animals; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Inflammation; Mammary Neoplasms, Experimental; Organotechnetium Compounds; Radiation Dosage; Radioactive Tracers; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tissue Distribution; Tyrosine | 2012 |
PET of HER2-positive pulmonary metastases with 18F-ZHER2:342 affibody in a murine model of breast cancer: comparison with 18F-FDG.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Recombinant Fusion Proteins | 2012 |
Reproducibility of static and dynamic (18)F-FDG, (18)F-FLT, and (18)F-FMISO MicroPET studies in a murine model of HER2+ breast cancer.
Topics: Animals; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Misonidazole; Models, Biological; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Reproducibility of Results | 2013 |
Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Blotting, Western; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Fulvestrant; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; Neoplasm Transplantation; Norpregnenes; Positron-Emission Tomography; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Receptors, Steroid; STAT1 Transcription Factor | 2012 |
Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Mice, SCID; Receptor, ErbB-2; Trastuzumab; Xenograft Model Antitumor Assays | 2013 |
Adduct of 2-[18F]FDG and 2-nitroimidazole as a putative radiotracer for the detection of hypoxia with PET: synthesis, in vitro- and in vivo-characterization.
Topics: Animals; Carcinoma 256, Walker; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HeLa Cells; Humans; In Vitro Techniques; Mammary Neoplasms, Experimental; Nitroimidazoles; Radiochemistry; Radiopharmaceuticals; Rats; Rats, Wistar; Tomography, Emission-Computed; Tumor Cells, Cultured | 2002 |
Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
Topics: Animals; Antimetabolites, Antineoplastic; Coordination Complexes; Copper Radioisotopes; Deoxyglucose; Drug Synergism; Fluorodeoxyglucose F18; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Organometallic Compounds; Radiation-Sensitizing Agents; Radionuclide Imaging; Radiopharmaceuticals; Thiosemicarbazones | 2003 |
Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
Topics: Animals; Colonic Neoplasms; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms, Experimental; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Rabbits; Radiopharmaceuticals; Rats; Tomography, Emission-Computed; Transplantation, Heterologous | 2003 |
Positron emitting 18F-2-deoxy-2-fluoro-D-glucose: potential hot new therapy.
Topics: Animals; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammary Neoplasms, Experimental; Mice; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer.
Topics: Animals; Apoptosis; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Transgenic; Necrosis; Neoplasm Metastasis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Radiotherapeutic use of 2-deoxy-2-[18F]fluoro-D-glucose--a comment.
Topics: Animals; Apoptosis; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammary Neoplasms, Experimental; Mice; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Positherapy: targeted nuclear therapy of breast cancer with 18F-2-deoxy-2-fluoro-D-glucose.
Topics: Animals; Female; Fluorescent Antibody Technique; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 1; Glucose Transporter Type 4; Immunoblotting; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mice, Transgenic; Monosaccharide Transport Proteins; Muscle Proteins; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Oxygen Consumption; Partial Pressure; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals | 2005 |
Registration of [18F]FDG microPET and small-animal MRI.
Topics: Animals; Female; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stereotaxic Techniques; Surgery, Computer-Assisted; Tumor Cells, Cultured | 2005 |
Uridylate trapping induced by the C-2-modified D-glucose analogs glucosone, fluoroglucose, and glucosamine.
Topics: Animals; Cells, Cultured; Chromatography, High Pressure Liquid; Deoxy Sugars; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucosamine; Glucose; Ketoses; Liver Neoplasms, Experimental; Mammary Neoplasms, Experimental; Mice; Nucleotides; Rats; Uracil Nucleotides | 1982 |
Pharmacokinetics and metabolism of 2-[18F]fluoro-2-deoxy-D-glucose (FDG) in mammary tumors of antiestrogen-treated rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Brain; Chromatography, High Pressure Liquid; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Kinetics; Mammary Neoplasms, Experimental; Myocardium; Rats; Rats, Sprague-Dawley; Skin; Time Factors; Tissue Distribution | 1995 |
Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important?
Topics: Animals; Autoradiography; Deoxyglucose; Female; Fluorodeoxyglucose F18; Macrophage-1 Antigen; Macrophages; Mammary Neoplasms, Experimental; Proliferating Cell Nuclear Antigen; Radionuclide Imaging; Rats; Rats, Inbred Lew; Tritium | 1995 |
Fluorine-18-fluorodeoxyglucose-guided breast cancer surgery with a positron-sensitive probe: validation in preclinical studies.
Topics: Animals; Beta Particles; Breast Neoplasms; Deoxyglucose; Equipment Design; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Mammary Neoplasms, Experimental; Phantoms, Imaging; Radioimmunodetection; Rats; Rats, Inbred Lew | 1995 |
Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Liver Neoplasms, Experimental; Mammary Neoplasms, Experimental; Methionine; Mice; Mice, Inbred C3H; Radionuclide Imaging | 1995 |
Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study.
Topics: Animals; Autoradiography; Cell Cycle; Cell Division; Deoxyglucose; DNA, Neoplasm; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Iodine Radioisotopes; Liver Neoplasms, Experimental; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Necrosis; Neoplasms, Experimental; Radionuclide Imaging; Serum Albumin, Bovine; Thymidine | 1994 |
Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake.
Topics: Animals; Autoradiography; Deoxyglucose; Female; Fluorodeoxyglucose F18; Granulation Tissue; Liver Neoplasms, Experimental; Macrophages; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Radionuclide Imaging; Tissue Distribution; Tritium | 1994 |
Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
Topics: Animals; Autoradiography; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Immunohistochemistry; Mammary Neoplasms, Experimental; Monosaccharide Transport Proteins; Rats; Rats, Inbred Lew | 1996 |
Insulin-induced hypoglycemia decreases uptake of 2-[F-18]fluoro-2-deoxy-D-glucose into experimental mammary carcinoma.
Topics: Animals; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hypoglycemia; Insulin; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Lew | 1997 |
FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models.
Topics: Animals; Cell Division; Deoxyglucose; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glycolysis; Hexokinase; Male; Mammary Neoplasms, Experimental; Monosaccharide Transport Proteins; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tomography, Emission-Computed | 1994 |
Effect of insulin on uptake of FDG by experimental mammary carcinoma in diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Fluorodeoxyglucose F18; Insulin; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Rats; Rats, Inbred Lew; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 1998 |
Feasibility of imaging photodynamic injury to tumours by high-resolution positron emission tomography.
Topics: Animals; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematoporphyrin Photoradiation; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Positron emission tomography of murine liver metastases and the effects of treatment by combretastatin A-4.
Topics: Animals; Antineoplastic Agents, Phytogenic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Liver Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Radiopharmaceuticals; Stilbenes; Tomography, Emission-Computed | 1999 |
High-resolution PET imaging for in vivo monitoring of tumor response after photodynamic therapy in mice.
Topics: Aluminum; Animals; Antineoplastic Agents; Dihematoporphyrin Ether; Feasibility Studies; Fluorodeoxyglucose F18; Indoles; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Radiolabelled 5'-iodo-2'-deoxyuridine: a promising alternative to [18F]-2-fluoro-2-deoxy-D-glucose for PET studies of early response to anticancer treatment.
Topics: Animals; Antineoplastic Agents; Estradiol; Female; Fluorodeoxyglucose F18; Idoxuridine; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Radiopharmaceuticals; Rats; Regional Blood Flow; Regression Analysis; Technetium Tc 99m Exametazime; Tomography, Emission-Computed | 1999 |
Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose.
Topics: Animals; Binding Sites; Carbon Dioxide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hypoxia; Mammary Neoplasms, Experimental; Mice; Misonidazole; Oxygen; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
[[(18)F]N-(4'-fluorobenzyl)-4-(3-bromophenyl) acetamide for imaging the sigma receptor status of tumors: comparison with [(18)F]FDG, and [(125)I]IUDR.
Topics: Acetamides; Adenocarcinoma; Animals; Female; Fluorodeoxyglucose F18; Idoxuridine; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, sigma; Tissue Distribution | 2001 |
Metabolic fate of 18F-FDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Female; Fluorodeoxyglucose F18; Liver; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 2002 |
Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma.
Topics: Animals; Blood Glucose; Cell Line; Deoxyglucose; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Rats; Rats, Inbred Lew; Tissue Distribution | 1992 |
Imaging of rats with mammary cancer with two 2-deoxy-2-[18F]fluoro-D-hexoses.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fucose; Galactose; Mammary Neoplasms, Experimental; Radionuclide Imaging; Rats; Rats, Inbred Strains | 1989 |
Rats with mammary cancer treated with toremifene and interferon: morphometry and needle aspiration biopsy for determination of ATP and 14C-fluorodeoxyglucose content.
Topics: Adenosine Triphosphate; Animals; Biopsy, Needle; Deoxy Sugars; Deoxyglucose; Female; Fluorodeoxyglucose F18; Interferon-gamma; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Recombinant Proteins; Tamoxifen; Toremifene | 1989 |
Comparative double-tracer whole-body autoradiography: uptake of 11C-, 18F- and 3H-labeled compounds in rat tumors.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Carcinoma 256, Walker; Deoxy Sugars; Deoxyglucose; Estrogen Antagonists; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Mammary Neoplasms, Experimental; Methionine; Rats; Rats, Inbred Strains; Tamoxifen; Thymidine; Tissue Distribution; Toremifene; Tritium | 1988 |
Dynamic (18F)-2-fluoro-2-deoxy-D-glucose (FDG) scintigraphy of normal and tumor-bearing rats.
Topics: Animals; Brain; Deoxy Sugars; Deoxyglucose; Female; Fluorodeoxyglucose F18; Half-Life; Heart; Kidney; Kidney Neoplasms; Liver; Mammary Neoplasms, Experimental; Pentetic Acid; Radioisotope Renography; Rats; Rats, Inbred Strains; Sarcoma, Avian; Technetium; Technetium Tc 99m Pentetate | 1986 |
Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucose.
Topics: Animals; Deoxy Sugars; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Liver Neoplasms, Experimental; Male; Mammary Neoplasms, Experimental; Mice; Radioisotopes; Radionuclide Imaging; Rats | 1986 |